相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protein kinase D and Gβγ mediate sustained nociceptive signaling by biased agonists of protease-activated receptor-2
Peishen Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Potential Markers from Serum-Purified Exosomes for Detecting Oral Squamous Cell Carcinoma Metastasis
Cuiping Li et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Prostate cancer cells and exosomes in acidic condition show increased carbonic anhydrase IX expression and activity
Mariantonia Logozzi et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells
Yuhong Jiang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome
Nestor N. Jimenez-Vargas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Neutrophil-Mediated Endogenous Analgesia Contributes to Sex Differences in Oral Cancer Pain
Nicole N. Scheff et al.
FRONTIERS IN INTEGRATIVE NEUROSCIENCE (2018)
Segmental isotopic labeling of a single-domain globular protein without any refolding step by an asparaginyl endopeptidase
Kornelia M. Mikula et al.
FEBS LETTERS (2017)
Suppression of asparaginyl endopeptidase attenuates breast cancer-induced bone pain through inhibition of neurotrophin receptors
Peng Yao et al.
MOLECULAR PAIN (2017)
Transforming Growth Factor-β1/Activin Receptor-like Kinase 5-Mediated Cell Migration is Dependent on the Protein Proteinase-Activated Receptor 2 but not on Proteinase-Activated Receptor 2-Stimulated Gq-Calcium Signalingle
Hendrik Ungefroren et al.
MOLECULAR PHARMACOLOGY (2017)
Ex vivo nonviral gene delivery of μ-opioid receptor to attenuate cancer-induced pain
Seiichi Yamano et al.
PAIN (2017)
Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission
Rebecca E. Yarwood et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Legumain is activated in macrophages during pancreatitis
Laura E. Edgington-Mitchell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Pathophysiological roles of proteases in gastrointestinal disease
Laura E. Edgington-Mitchell
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Structure and function of legumain in health and disease
Elfriede Dall et al.
BIOCHIMIE (2016)
Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease-activated receptor-2
T. Lieu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Development of a potent and selective cell penetrant Legumain inhibitor
Kerry A. Ness et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo
Scott Boitano et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain
Peishen Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
TRPV1 expression level in isolectin B4-positive neurons contributes to mouse strain difference in cutaneous thermal nociceptive sensitivity
Kentaro Ono et al.
JOURNAL OF NEUROPHYSIOLOGY (2015)
Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer
Laura E. Edgington-Mitchell et al.
ONCOTARGET (2015)
IB4(+) and TRPV1(+) sensory neurons mediate pain but not proliferation in a mouse model of squamous cell carcinoma
Yi Ye et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2014)
Pathway-selective antagonism of proteinase activated receptor 2
J. Y. Suen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Cathepsin S Causes Inflammatory Pain via Biased Agonism of PAR2 and TRPV4
Peishen Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Adenosine triphosphate drives head and neck cancer pain through P2X2/3 heterotrimers
Yi Ye et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
The Bile Acid Receptor TGR5 Does Not Interact with β-Arrestins or Traffic to Endosomes but Transmits Sustained Signals from Plasma Membrane Rafts
Dane D. Jensen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Functional Imaging of Legumain in Cancer Using a New Quenched Activity-Based Probe
Laura E. Edgington et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Effects of legumain as a potential prognostic factor on gastric cancers
Na Li et al.
MEDICAL ONCOLOGY (2013)
Association of legumain expression pattern with prostate cancer invasiveness and aggressiveness
Yoshio Ohno et al.
WORLD JOURNAL OF UROLOGY (2013)
Activation of legumain involves proteolytic and conformational events, resulting in a context- and substrate-dependent activity profile
Elfriede Dall et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2012)
Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110)
J. Y. Suen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Novel Animal Models of Acute and Chronic Cancer Pain: A Pivotal Role for PAR2
David K. Lam et al.
JOURNAL OF NEUROSCIENCE (2012)
Targeting Cell Surface Alpha(v)beta(3) Integrin Increases Therapeutic Efficacies of a Legumain Protease-Activated Auristatin Prodrug
Yuan Liu et al.
MOLECULAR PHARMACEUTICS (2012)
Nav1.8 expression is not restricted to nociceptors in mouse peripheral nervous system
Shannon D. Shields et al.
PAIN (2012)
Molecular crosstalk between cancer cells and tumor microenvironment components suggests potential targets for new therapeutic approaches in mobile tongue cancer
Dan Dayan et al.
CANCER MEDICINE (2012)
Nerve Growth Factor Links Oral Cancer Progression, Pain, and Cachexia
Yi Ye et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Development of Near-Infrared Fluorophore (NIRF)-Labeled Activity-Based Probes for in Vivo Imaging of Legumain
Jiyoun Lee et al.
ACS CHEMICAL BIOLOGY (2010)
Distinct Protease Requirements for Antigen Presentation In Vitro and In Vivo
Stephen P. Matthews et al.
JOURNAL OF IMMUNOLOGY (2010)
The dolognawmeter: A novel instrument and assay to quantify nociception in rodent models of orofacial pain
John C. Dolan et al.
JOURNAL OF NEUROSCIENCE METHODS (2010)
Serine proteases and protease-activated receptor 2-dependent allodynia: A novel cancer pain pathway
D. K. Lam et al.
PAIN (2010)
Dual effect of the novel peptide antagonist K-14585 on proteinase-activated receptor-2-mediated signalling
Fui Goon Goh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Protein Kinase D Isoforms Are Expressed in Rat and Mouse Primary Sensory Neurons and Are Activated by Agonists of Protease-Activated Receptor 2
Silvia Amadesi et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2009)
Agonist-Biased Signaling via Proteinase Activated Receptor-2: Differential Activation of Calcium and Mitogen-Activated Protein Kinase Pathways
Rithwik Ramachandran et al.
MOLECULAR PHARMACOLOGY (2009)
Effect of peripheral endothelin-1 concentration on carcinoma-induced pain in mice
Victoria Pickering et al.
EUROPEAN JOURNAL OF PAIN (2008)
Validation of the University of California San Francisco Oral Cancer Pain Questionnaire
Antonia Kolokythas et al.
JOURNAL OF PAIN (2007)
Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain
Yi Dai et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Peripheral endothelin A receptor antagonism attenuates carcinoma-induced pain
Brian L. Schmidt et al.
EUROPEAN JOURNAL OF PAIN (2007)
Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice
Andrew D. Grant et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Prevalence of pain in patients with cancer: a systematic review of the past 40 years
M. H. J. Van den Beuken-Van Everdingen et al.
ANNALS OF ONCOLOGY (2007)
Proteinase-activated receptors, targets for kallikrein signaling
Katerina Oikonomopoulou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cε- and A-dependent mechanisms in rats and mice
Silvia Amadesi et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer
Olga Vasiljeva et al.
CANCER RESEARCH (2006)
Substrate specificity of human kallikrein 6 - Salt and glycosaminoglycan activation effects
PF Angelo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Extracellular pH controls NHE1 expression in epidermis and keratinocytes: Implications for barrier repair
JR Hachem et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: Preliminary results
R Murthy et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2005)
Evaluation of pain in patients with oral squamous cell carcinoma
ST Connelly et al.
JOURNAL OF PAIN (2004)
Localization of mechanosensitive channel TRPV4 in mouse skin
M Suzuki et al.
NEUROSCIENCE LETTERS (2003)
Mammalian TRPV4 (VR-OAC) directs behavioral responses to osmotic and mechanical stimuli in Caenorhabditis elegans
W Liedtke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Abnormal osmotic regulation in trpv4-/- mice
W Liedtke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
PH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion
JP Hachem et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Continuous administration of the 5-hydroxytryptamine1A agonist (3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]-methadone (F 13640) attenuates allodynia-like behavior in a rat model of trigeminal neuropathic pain
K Deseure et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Impaired pressure sensation in mice lacking TRPV4
M Suzuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Direct phosphorylation of capsaicin receptor VR1 by protein Kinase Cε and identification of two target serine residues
M Numazaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway
N Vergnolle et al.
NATURE MEDICINE (2001)
Inhibition of cellular action of thrombin by N3-cyclopropyl-7-{[4-(1-methylethyl)phenyl]methyl}-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist
HS Ahn et al.
BIOCHEMICAL PHARMACOLOGY (2000)
β-Arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2
KA DeFea et al.
JOURNAL OF CELL BIOLOGY (2000)
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
M Steinhoff et al.
NATURE MEDICINE (2000)
分享论文
